Breathe Well Live Well
|
Boston Scientific reports encouraging data from asthma trial
TMC Net The research in severe asthma (RISA) trial is the third in a series of clinical trials that have completed five years of follow-up for patients treated with bronchial thermoplasty. In summary, bronchial thermoplasty has demonstrated a strong long-term … Long-term Safety and Effectiveness of Bronchial Thermoplasty Demonstrated in … |
View full post on asthma – Google News
|
Data Tracking for Asthma Sufferers?
Smart Data Collective Despite the recent privacy row with smartphones and other GPS enabled devices, a Wisconsin doctor is proposing use of an inhaler with built in global positioning system to track where and when asthma sufferers use their medication. … |
View full post on asthma – Google News
|
High-tech asthma inhaler tracks data via GPS
The Independent Asthma sufferers may want to upgrade their ordinary inhaler with the high-tech Spiroscout, a GPS and Wifi-enabled inhaler attachment that tracks your data, such as when and where you use your inhaler and which areas trigger attacks, and reminds you to … |
View full post on asthma – Google News
|
Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American …
PR Newswire (press release) There can be no assurance that that the data presented during the 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting regarding Cinryze is predictive of how Cinryze will perform in commercial usage. … |
View full post on asthma – Google News
|
Phase II Data On Reslizumab Suggest Compound Improves Asthma Control And Lung …
Biomed Middle East Phase II data presented on a new investigational compound called reslizumab suggest a trend toward improvement in asthma control associated with a … |
View full post on asthma – Google News
|
Phase II Data On Reslizumab Suggest Compound Improves Asthma Control And Lung …
Medical News Today (press release) Phase II data presented on a new investigational compound called reslizumab suggest a trend toward improvement in asthma control associated with a … |
View full post on asthma – Google News
|
KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy …
Trading Markets (press release) Ecallantide for Treatment of Acute Attacks of Acquired C1 Esterase Inhibitor Deficiency — Nisha S. Patel, MD, Asthma Allergy & Pulmonary Associates, … Dyax to present data of KALBITOR inhibitor for Angioedema at ACAAI Meeting |
View full post on asthma – Google News
|
KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy …
istockAnalyst.com (press release) … at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting held November 11-16, at the Phoenix Convention Center in Phoenix, AZ. … KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy … |
View full post on asthma – Google News
|
Cinryze(R) (C1 esterase inhibitor [human]) Data Presented at 2010 Annual …
Investor’s Business Daily … MD, of Allergy, Asthma, and Dermatology Associates in Lake Oswego, Ore. discussed the experience of 14 pregnant women who were enrolled in pivotal and … Cinryze® (C1 esterase inhibitor [human]) Data Presented at 2010 Annual Meeting … |
View full post on asthma – Google News
|
Cinryze® (C1 esterase inhibitor [human]) Data Presented at 2010 Annual Meeting …
PR Newswire (press release) There can be no assurance that that the data presented during the 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) … Cinryze(R) (C1 esterase inhibitor [human]) Data Presented at 2010 Annual … |
View full post on asthma – Google News